Full Press Release Details
Adam Koppel, Executive Vice President, Strategy and Business Development, to Return to Bain Capital.
BIIB
Adam Koppel, Executive Vice President, Strategy and Business Development, to Return to Bain Capital
Key Takeaway: Adam Koppel, Executive Vice President, Strategy and Business Development, to Return to Bain Capital
BiopharmaWatch Analysis
From our catalyst data and publicly available data · not financial adviceBest trade, last catalyst
+34%
120-day peak, hindsight
Typical move
1.8%
average across 15 past catalysts
Lead asset
Alefacept
Phase 3 · Chronic Plaque Psoriasis